Price
96
+1.69%52W Range
Market Cap
₹31.52 Cr
Traded: ₹0.00 Cr (0.00%) 0.0x
Free Float: ₹8.42 Cr (0.01% of FF traded)
Volume · 60D trend
122 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +8.0% | +35.0% | +20.0% | -- | +20.0% | Stable |
| ROE | -3.0% | -1.0% | -6.0% | -- | -- | Stable |
| Return | -- | -- | -- | +45.0% | -- | -- |
| Profit | +45.0% | +21.0% | +14.0% | -- | +12.0% | Decelerating |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11 | 7 | 10 | 9 | 9 | 6 | 8 | 9 | 7 | 2 | 6 | 5 | 6 | 5 |
| Expenses | 10 | 6 | 9 | 8 | 9 | 5 | 7 | 8 | 6 | 6 | 5 | 5 | 5 | 4 |
| Operating Profit | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | -4 | 1 | 1 | 1 | 1 |
| OPM % | 8.0% | 13.5% | 7.9% | 10.0% | 9.7% | 13.6% | 10.6% | 12.3% | 12.8% | -240.6% | 15.4% | 13.8% | 14.9% | 18.1% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax % | 25.7% | 0.0% | 28.0% | 28.3% | 25.6% | -60.9% | 25.6% | 26.1% | 26.5% | 89.5% | 0.0% | -61.1% | 55.0% | -76.2% |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Sales Growth (YoY) | 13.6% | 24.9% | 17.9% | 4.0% | 40.9% | 232.2% | 39.3% | 68.3% | 22.0% | -64.6% | 7.7% | 4.9% | 8.3% | -- |
| Sales Growth (QoQ) | -- | -22.3% | 2.5% | -0.9% | 58.4% | -26.6% | -9.7% | 34.2% | 273.3% | -69.2% | 9.1% | -2.7% | 8.3% | -- |
| OP Growth (YoY) | -6.5% | 24.7% | -11.6% | -15.3% | 7.0% | 118.7% | -4.4% | 50.0% | 4.9% | -570.7% | -- | -- | -- | -- |
| OP Growth (QoQ) | -14.9% | 32.9% | -19.1% | 2.2% | 13.6% | -5.8% | -22.5% | 29.1% | 119.9% | -581.1% | 21.6% | -9.8% | -10.9% | -- |
| Profit Growth (YoY) | -18.8% | 16.2% | -37.9% | -5.9% | 28.0% | 825.0% | 26.1% | 17.2% | 150.0% | -89.2% | 15.0% | 262.5% | -44.4% | 32.1% |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| OP Margin | -- | 13.5% | 7.9% | 10.0% | 9.7% | 13.6% | 10.6% | 12.3% | 12.8% | -240.6% | 15.4% | 13.8% | 14.9% | 18.1% |
| Net Margin | -- | 5.8% | 1.9% | 3.4% | 3.4% | 6.2% | 3.6% | 3.8% | 3.7% | 2.2% | 3.9% | 5.4% | 1.8% | 7.3% |
| Material Cost % | 45.4% | 32.1% | 45.6% | 37.7% | 42.7% | 19.6% | 37.1% | 36.5% | 32.1% | 81.1% | 21.0% | 20.3% | 23.1% | 20.2% |
| Employee Cost % | 12.4% | 16.2% | 13.2% | 13.8% | 13.0% | 21.6% | 14.2% | 12.6% | 14.4% | 44.4% | 10.6% | 11.6% | 10.0% | 11.8% |
| P/S | 0.85 | 0.92 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 2.30 | 2.41 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Newspaper advertisement for publication of unaudited financial results for the quarter ended June 30 2026.
approval of unaudited financial results for the quarter ended 30-06-2026 along with limited review report.
Approval of un-audited Financial Results along with Limited Review Report for the quarter ended on 30th June 2026 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015.
Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve ....
Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30-06-2026.
Intimation of closure of trading window for the quarter ended June 30 2026.
The Copy of newspaper advertisement of publication of audited financial results for the quarter and year ended March 31 2026.
as per attachment
Approval of audited financial results for the quarter and year ended 31st March 2026
Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve ....
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
compliances certificate under Reg74(5) of SEBI(DP) Regulations, 2018 for the quarter ended ended 31-03-2026.
intimation for closure of trading Window
As per attachment.
Approval of Standalone un-audited Financial Results for the quarter ended December 31 2025 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015 along with limited ....
approval of unaudited financial results for the quarter ended December 31 2025.
Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve ....
Compliance Certificate under regualtion 74(5) of SEBI (DP) Regulation 2018 for the quarter ended December 2025
Intimation For Closure Of Trading Window For Quarter ended 31st Dec 2025.
As per attachment
Resignation of Independent non-executive Director of the Company.
As per attachment.
As per attachment.
Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve ....
Compliances certificate under regulation 74(5) of SEBI (DP_ Regulations, 2018 for the qtr ended 30-09-2025.
Voting results and scrutinizer report for the annual geneal meeting held on 30-09-2025.
Proceeding of 36th Annual Genreal Meeting held on 30th September 2025
Intimation of closer of Trading window
As per attachment.
36th Annual Report for the Financial Year 2024 - 2025 pursuant to Compliance as per regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements [LODR]) Regulations, 2015.
Notice of 36th AGM
As per attachement
as per attachement
Notice of book closure for the purpose of annual general meetign to be held on September 30 2025
Re-appoinment of Managing Director of the compny , subject to approval of shareolders of the company at the ensuing annual general Meeting.
As per attachment.
as per attachment
as per attachment.
as per attachment.
Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 ,inter alia, to consider and approve ....
compliance-certificate under regulation 74(5) of SEBI(DP) regulation, 2018 for the quarter ended 30-06-2025
Closer of trading window
as per attachement
as per atttachment
This is to inform you that the Board of Directors of SHARMA EAST INDIA HOSPITALS AND MEDICAL RESEARCH LTD in their meeting held on today i.e., Friday the 23rd May 2025 at the registered ....
Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to consider and approve ....
as per attachment
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that that the Board ....
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Compliances certificate under regulation 74(5) of SEBI (DP) regulations, 2018 for the quarter ended March 31 2025